iHealthScreen Inc. Announces UK Medicines and Healthcare Products Regulatory Agency (MHRA) Certification and registration for iPredict™ - Automated AI System for Early Diagnosis of DR, AMD, and Glaucoma
iPredict™ AI Eye Screening System provides fully automated diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results.
- iPredict™ AI Eye Screening System provides fully automated diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results.
- The entire test can easily and reliably be completed within 5 minutes.
- iPredict-AMD can detect referable AMD such as intermediate to late AMD and non-referable AMD such as early or none.
- iPredict is indicated for use by healthcare providers in clinics, hospitals, or other healthcare facilities to automatically detect DR, AMD, and glaucoma suspects.